metricas
covid
Buscar en
Annals of Hepatology
Toda la web
Annals of Hepatology Most often read
Journal Information

Most often read

953695
Skin manifestations of liver diseases
A. Koulaouzidis;, S. Bhat;, J. Moschos
Ann Hepatol. 2007;6:181-4
953695
Open access
134220
COVID-19 and the liver: What do we know after six months of the pandemic?
Nora A. Fierro
Ann Hepatol. 2020;19:590-1
134220
Open access
Open Article
96463
Effects of systemic chemotherapy on the liver
Giuliano Ramadori, Silke Cameron
Ann Hepatol. 2010;9:133-43
96463
Open access
82207
Anti-hepatitis B virus activity of food nutrients and potential mechanisms of action
Alexis Jose-Abrego, Ingrid Rivera-Iñiguez, Luis A. Torres-Reyes, Sonia Roman
Ann Hepatol. 2023;28:100766
82207
Full text access
70755
Bile Acid Physiology
Agostino Di Ciaula, Gabriella Garruti, Raquel Lunardi Baccetto, Emilio Molina-Molina, Leonilde Bonfrate, David Q.-H. Wang, Piero Portincasa
Ann Hepatol. 2017;16 Supl 1:S4-S14
70755
Open access
62804
Diagnosis of liver nodules within and outside screening programs
Massimo Colombo
Ann Hepatol. 2015;14:304-9
62804
Open access
59296
Patterns of viral load in chronic hepatitis B patients in Brazil and their association with ALT levels and HBeAg status
Marcelo Eidi Nita, Nelson Gaburo, Hugo Cheinquer, Gilbert L’ltalien, Evaldo Stanislau Affonso de Araujo, Patricia Mantilla, Nancy Cure-Bolt, Paulo A. Lotufo
Ann Hepatol. 2009;8:339-45
59296
Open access
43530
Treatment of hyperferritinemia
Melanie D. Beaton, Paul C. Adams
Ann Hepatol. 2012;11:294-300
43530
Open access
42901
Current concepts in alcohol metabolism
Juan Caballería
Ann Hepatol. 2003;2:60-8
42901
Open access
42598
Transmission routes of hepatitis C virus infection
Eduardo Zumaeta Villena
Ann Hepatol. 2006;5 Supl 1:S12-4
42598
Open access
41653
Shark liver oil: hidden dangers
Serta Kilincalp, Murat Deveci, Omer Basar, Fuat Ekiz, Sahin Coban, Osman Yuksel
Ann Hepatol. 2012;11:728-30
41653
Open access
40004
Guidelines for the diagnosis and treatment of extrahepatic portal vein obstruction (EHPVO) in children
Judith Flores-Calderón, Segundo Morán-Villota, Solange-Heller Rouassant, Jesús Nares-Cisneros, Flora Zárate-Mondragón, Beatriz González-Ortiz, José Antonio Chávez-Barrera, Rodrigo Vázquez-Frías, ... Gustavo Varela-Fascinetto
Ann Hepatol. 2013;12 Supl 1:S3-S24
40004
Open access
39287
Current concepts in acute liver failure
Maximiliano Rovegno, Magdalena Vera, Alex Ruiz, Carlos Benítez
Ann Hepatol. 2019;18:543-52
39287
Open access
38835
Ocular manifestations of liver disease in children: Clinical aspects and implications
Durga Prasad, Arpita Bhriguvanshi
Ann Hepatol. 2020;19:608-13
38835
Open access
37015
Cholesterol and Lipoprotein Metabolism and Atherosclerosis: Recent Advances in Reverse Cholesterol Transport
Helen H. Wang, Gabriella Garruti, Min Liu, Piero Portincasa, David Q.-H. Wang
Ann Hepatol. 2017;16 Supl 1:S27-42
37015
Open access
36505
Beta blockers in portal hypertension. Are they really a good option?
Eric López-Méndez, Misael Uribe
Ann Hepatol. 2006;5:86-91
36505
Open access
35261
Hepatic Hydrothorax
Yong Lv, Guohong Han, Daiming Fan
Ann Hepatol. 2018;17:33-46
35261
Open access
34125
The relative expression of hepatocellular and cholestatic liver enzymes in adult patients with liver disease
Daniel Iluz-Freundlich, Manna Zhang, Julia Uhanova, Gerald Y. Minuk
Ann Hepatol. 2020;19:204-8
34125
Open access
32721
Anti-cancer effects of blue-green alga Spirulina platensis, a natural source of bilirubin-like tetrapyrrolic compounds
Renata Koníčková, Kateřina Vaňková, Jana Vaníková, Katerina Vánová, Lucie Muchová, Iva Subhanová, Marie Zadinová, Jaroslav Zelenka, ... Libor Vítek
Ann Hepatol. 2014;13:273-83
32721
Open access
29510
Silymarin is an ally against insulin resistance: A review
Karla MacDonald-Ramos, Layla Michán, Alejandra Martínez-Ibarra, Marco Cerbón
Ann Hepatol. 2021;23C:255
29510
Open access